eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
5/2011
vol. 6
 
Share:
Send email
Share:
abstract:
Review paper

Pathomechanism of insulin resistance in chronic hepatitis C

Michał Kukla
,
Tomasz Sawczyn
,
Krystyna Żwirska-Korczala
,
Mirosław Jarosz

Przegląd Gastroenterologiczny 2011; 6 (5): 284–289
DOI: https://doi.org/10.5114/pg.2011.25376
Online publish date: 2011/11/11
View full text Get citation
 
PlumX metrics:
Chronic hepatitis C (CHC) should be considered not only as viral but also as a metabolic disease. Insulin resistance (IR), impaired glucose tolerance, type 2 diabetes mellitus, hepatic steatosis, lipid metabolism abnormalities and probably atherosclerosis are the main metabolic manifestations of CHC. The development of IR in CHC seems to be complex, resulting from an ongoing inflammatory process, up-regulation of pro-inflammatory cytokines, fibrosis progression and direct influence of the virus on the insulin signalling pathway. Insulin resistance promotes hepatic steatosis and is associated with fibrosis progression, resistance to antiviral therapy and development of hepatocellular carcinoma. Therefore, understanding the pathogenesis of this phenomenon may by essential to obtain higher efficacy of antiviral therapy and would be helpful in prevention of metabolic disturbances and complications in the course of CHC.
keywords:

insulin resistance, chronic hepatitis C, adipokines, fibrosis, liver
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.